explore -WSS

explore

author：Wikipedia 2025-09-06 02:04:19 - browse：2

Balance innovation — A federal judge made a key ruling in a lawsuit challenging a new drug pricing program Adobe

WASHINGTON — A federal court judge allowed a new Medicare drug price negotiation program to proceed while the court deliberates whether it is constitutional.

The case centers on Democrats’ new law, which empowered the Medicare program to start negotiating lower prices for certain medicines that are especially expensive for the government. Judge Michael Newman, a Trump appointee to the U.S. District Court for the Southern District of Ohio, ruled against the U.S. Chamber of Commerce, which had sued the federal government and asked for the program to be stopped while litigation continues.

Medicare officials announced the first 10 drugs they would negotiate over last month, and the deadline for the pharmaceutical companies to sign agreements to start bargaining is Oct. 1. The Chamber of Commerce had requested a decision on the preliminary injunction by that date.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： FDA struggles to regulate food additives, sometimes for decades

WSS

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Mike Pence clashes with Tucker Carlson in Iowa

CEOs share strategies for surviving biotech slump

Global childhood vaccinations edge closer to pre

HHS leader on health, climate change and biopharma emissions

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

hotspot

explore

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Jerome Adams on the need for new antivirals for Covid

2023 STAT Wunderkinds: get to know the winners

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How climate

Bright Health sells Medicare Advantage business to Molina

Solve the antibiotic resistance crisis with preventive drugs

United colonoscopy coverage change 'may cost lives,' doctors say

STAT Readout Newsletter: Today's biggest biotech updates

leisure time

CEOs share strategies for surviving biotech slump

Pharmacists can make shortage drugs, but at what cost?

CEOs share strategies for surviving biotech slump

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Can CDC director Mandy Cohen drive consensus in Washington?

Does aspartame cause cancer? What new WHO guidance says

hotspot

entertainment

knowledge

knowledge